Genetic & Genomic MedicinemedRxivPreprint
Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer
Min Jiang, Dongming Zhang, Yi-Ching Hsueh…·Gang Niu
The paper predicts ROR1 and CAV1 expression from whole-exome sequencing data to assess response to B013 plus nab-paclitaxel in triple-negative breast cancer, showing agreement with observed responses in 9 out of 10 patients.
DOI 10.64898/2026.09.30.26364376